|
Mechanism30S subunit inhibitors [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date02 Jun 1971 |
100 Clinical Results associated with Liaoning Beiqi Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Liaoning Beiqi Pharmaceutical Co., Ltd.
100 Deals associated with Liaoning Beiqi Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Liaoning Beiqi Pharmaceutical Co., Ltd.